Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients

Shan Yu,1 Yan Wang,1 Xi Cheng,2 Minzhi Lv,3 Yuehong Cui,1 Wei Li,1 Yiyi Yu,1 Qian Li,1 Tianshu Liu1,4 1Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China; 2Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yu S, Wang Y, Cheng X, Lv M, Cui Y, Li W, Yu Y, Li Q, Liu T
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2020-10-01
Col·lecció:Cancer Management and Research
Matèries:
gastric cancer
gastrectomy
adjuvant chemotherapy
capecitabine
oxaliplatin
s-1
xelox
Accés en línia:https://www.dovepress.com/prognosis-of-adjuvant-sox-vs-xelox-chemotherapy-for-gastric-cancer-aft-peer-reviewed-article-CMAR
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars